Oxford vaccine trial continues amid death report

Latest News

Oxford vaccine trial continues amid death report

Thursday, October 22, 2020

Print this page Email A Friend!


LONDON, United Kingdom (AP) — The University of Oxford says the late-stage trial of its COVID-19 vaccine in Brazil will continue following reports of a participant's death.

The university said it can't comment on specific incidents but an independent review found no reason to be concerned about the safety of the Brazilian trial.

It said an “independent review, in addition to the Brazilian regulator, have recommended that the trial should continue”.

The Oxford vaccine is being developed in conjunction with the international pharmaceutical company AstraZeneca.

Trials are underway in the United States and the UK, as well as Brazil, to determine whether the potential vaccine is safe and effective in humans.


Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at http://bit.ly/epaper-login


ADVERTISEMENT




POST A COMMENT

HOUSE RULES

1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper � email addresses will not be published.

2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.

3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.

4. Please do not write in block capitals since this makes your comment hard to read.

5. Please don't use the comments to advertise. However, our advertising department can be more than accommodating if emailed: advertising@jamaicaobserver.com.

6. If readers wish to report offensive comments, suggest a correction or share a story then please email: community@jamaicaobserver.com.

7. Lastly, read our Terms and Conditions and Privacy Policy



comments powered by Disqus
ADVERTISEMENT

Poll

ADVERTISEMENT
ADVERTISEMENT

Today's Cartoon

Click image to view full size editorial cartoon
ADVERTISEMENT